This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 105 
1 out of 1,853 
Years Active: 2025
Title: Maikel Luis Colli: Innovator in Diabetes Research
Introduction
Maikel Luis Colli is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of diabetes research, particularly through his innovative work on antigenic peptides.
Latest Patents
Colli holds a patent titled "Antigenic Peptides Deriving from Secretogranin V and Uses Thereof for the Diagnosis and Treatment of Type 1 Diabetes." This patent highlights his dedication to advancing medical science and improving treatment options for individuals with diabetes. He has 1 patent to his name.
Career Highlights
Throughout his career, Colli has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université de Paris. His work in these organizations has allowed him to explore groundbreaking research and contribute to the scientific community.
Collaborations
Colli has collaborated with notable colleagues, including Roberto Mallone and Joëlle Vinh. These partnerships have further enriched his research and expanded the impact of his work in the field.
Conclusion
Maikel Luis Colli is a dedicated inventor whose work in diabetes research is paving the way for new diagnostic and treatment methods. His contributions are vital to the ongoing fight against Type 1 diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile